Development and Modeling of a Dengue Vaccine for Children Aged 10-14 in Rio de Janeiro, Brazil
DOI:
https://doi.org/10.5540/03.2025.011.01.0379Palabras clave:
Dengue Vaccine Model, Vaccine Efficacy, Vaccination RatesResumen
This study introduces a model for developing a dengue vaccine program for children aged 10-14 in Rio de Janeiro, Brazil. We simulate dengue spread and vaccination impacts over three years, focusing on vaccine efficacies, timing, and stochastic rates within a SIRS-V framework. Our findings highlight the importance of vaccine efficacy and timing in reducing infections and managing outbreaks. Even with lower efficacy, early vaccination significantly reduces infection peaks and delays epidemic onset. While there are discrepancies with actual data, suggesting model refinement, our results emphasize the value of targeted vaccination strategies in controlling dengue. This research offers insights for policymakers on optimizing dengue control through timely and effective vaccination campaigns.
Descargas
Citas
G. Amaral. Fiotec-Fiocruz, Brasil pode registrar recorde de casos de dengue em 2024. Online. Acessado em 30/03/2024, https://www.fiotec.fiocruz.br/noticias/outros/8409.
BRASIL. Ministério da Saúde, TABNET DATASUS. Online. Acessado em 30/03/2024, https://datasus.saude.gov.br/informacoes-de-saude-tabnet.
COE. Centro de Operação de Emergência do Ministério da Saúde, Informe Semanal, Nº 06, SE 01 a 11/2024. Online. Acessado em 30/03/2024, https://www.gov.br/saude/pt-br/assuntos/saude-de-a-a-z/a/arboviroses/informe-semanal/informe-semanal-no-03-coe-se-8-27-de-fevereiro-de-2024.
Z. Feng and J. X. Velasco-Hernández. “Competitive exclusion in a vector-host model for the dengue fever”. In: Journal of Mathematical Biology 35 (1997), pp. 523–544.
A. Mishra and S. Gakkhar. “The effects of awareness and vector control on two strains dengue dynamics”. In: Applied Mathematics and Computation 246 (2014), pp. 159–167.
L. Rivera, S. Biswal, X. Sáez-Llorens, H. Reynales, E. López-Medina, C. Borja-Tabora, L. Bravo, C. Sirivichayakul, P. Kosalaraksa, L. Martinez-Vargas, et al. “Three-year efficacy and safety of Takeda’s dengue vaccine candidate (TAK-003)”. In: Clinical Infectious Diseases 75.1 (2022), pp. 107–117.
E. Shim. “Optimal dengue vaccination strategies of seropositive individuals”. In: Mathematical Biosciences and Engineering 16.3 (2019), pp. 1171–1189.